Merck KGaA (XTER:MRK)
€ 141.85 0.25 (0.18%) Market Cap: 61.67 Bil Enterprise Value: 69.21 Bil PE Ratio: 23.06 PB Ratio: 2.19 GF Score: 85/100

Q2 2024 Merck KGaA Earnings Call Transcript

Aug 01, 2024 / 12:00PM GMT
Release Date Price: €168.3 (+1.51%)
Operator

Dear ladies and gentlemen, welcome to the Merck investor and analyst conference call on the second quarter 2024. (Operator Instructions)

I am now handing over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.

Constantin Fest
Merck KGaA - Head of Investor Relations

Thank you very much, Heidi, and a very warm welcome from my side to this Merck Q2 2024 results call. My name is Constantin Fest. I'm Head of Investor Relations here at Merck.

And I'm delighted to have today here with me Belén Garijo, the Group CEO; as well as Helene von Roeder, Group CFO. Also, joining for the Q&A part of this call, we have Matthias Heinzel, CEO of Life Science; as well as Peter Guenter, CEO of Healthcare; and Kai Beckmann, CEO of Electronics.

In the first few minutes of this call, we would like to guide you through the key slides of this presentation. After that, we'd be happy to take all of your questions.

With this, we are ready to directly start, and I'd like to now hand

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot